ELCC 2026: Co-mutations in EGFR-mutated NSCLC

In this MEDtalk from ELCC 2026, Fredrik Enlund, Associate Professor and Head of Diagnostic Center at Kalmar County Hospital, presents a pilot study of patients with EGFR-mutated lung adenocarcinoma. NGS analysis identified additional mutations, including RET and HIF-1, that differed between patients with shorter and longer survival.